Table 2.
Effect of respondent variables on proportion of respondents being in consensus on each of the four specific questions related to management of hepatitis C virus infected alcoholic hepatitis patients
| Respondent variable |
Routine screening for HCV |
HCV does not change treatment approach |
HCV does not affect response to corticosteroids |
HCV does not affect treatment
response to pentoxifylline |
||||||||
| n (%) | P value | OR (95%CI) | n (%) | P value | OR (95%CI) | n (%) | P value | OR (95%CI) | n (%) | P value | OR (95%CI) | |
| Age (yr) < 35 35-44 45-54 ≥ 55 | 0.2 | 0.7 | 0.8 | 0.75 | ||||||||
| 68 (92) | 1 | 51 (76) | 1 | 54 (83) | 1 | 59 (91) | 1 | |||||
| 85 (90) | 0.8 (0.3-2.5) | 66 (73) | 1.3 (0.6-3) | 69 (77) | 0.6 (0.3-1.3) | 79 (89) | 0.9 (0.3-2.8) | |||||
| 99 (96) | 2.1 (0.5-8) | 73 (78) | 0.9 (0.4-2) | 75 (81) | 0.7 (0.3-1.6) | 85 (93) | 1.7 (0.5-6) | |||||
| 88 (97) | 2.5 (0.6-11) | 58 (72) | 1.4 (0.6-3) | 63 (79) | 0.6 (0.3-1.5) | 73 (91) | 1.3 (0.4-4.2) | |||||
| Specialty GE HP | 0.37 | 0.5 | 0.2 | 0.55 | ||||||||
| 183 (93) | 1 | 135 (73) | 1 | 135 (77) | 1 | 160 (92) | 1 | |||||
| 157 (95) | 1.5 (0.6-3.7) | 113 (77) | 0.8 (0.5-1.4) | 126 (83) | 0.7 (0.4-1.2) | 136 (90) | 1.3 (0.6-2.7) | |||||
| Patients (n/yr) < 30 ≥ 30 | 0.29 | 0.6 | 0.2 | 0.38 | ||||||||
| 299 (93) | 1 | 221 (75) | 1 | 232 (81) | 1 | 259 (91) | 1 | |||||
| 41 (98) | 2.9 (0.4-22.0) | 27 (71) | 1.3 (0.6-2.7) | 29 (73) | 1.6 (0.7-3.3) | 37 (95) | 0.5 (0.1-2.3) | |||||
| HCV prevalence < 20% ≥ 20% | 0.48 | 0.3 | 0.2 | 0.81 | ||||||||
| 148 (95) | 0.7 (0.3-1.8) | 104 (72) | 0.8 (0.5-1.3) | 119 (83) | 1.4 (0.8-2.5) | 129 (91) | 1.1 (0.5-2.4) | |||||
| 188 (93) | 1 | 143 (77) | 1 | 141 (77) | 1 | 166 (91) | 1 | |||||
HCV: Hepatitis C virus; GE: Gastroenterology; HP: Hepatology. Also shown are results of logistic regression analyses for each respondent variable given as odds ratio (OR) with 95% confidence interval (CI).